Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Metoprolol and Lisinopril Combination Therapy for Cardiovascular Disease Management

Efficacy and Safety of the Combination

  • The European Society of Cardiology recommends that beta-blockers, including metoprolol, can be effectively combined with any of the other major blood pressure-lowering drug classes when there are compelling indications for their use 1
  • The American College of Cardiology suggests that the combination of beta-blockers with ACE inhibitors is particularly beneficial in patients with specific cardiovascular conditions such as heart failure with reduced ejection fraction (HFrEF) 2, 3
  • The American College of Cardiology recommends metoprolol succinate and bisoprolol as preferred beta-blockers in patients with HFrEF 2, 4
  • The European Society of Cardiology guidelines recommend specific two-drug combinations for hypertension management, with preferred combinations being a renin-angiotensin system (RAS) blocker (such as an ACE inhibitor like lisinopril) with either a dihydropyridine calcium channel blocker or a diuretic 1
  • The American College of Cardiology suggests that while beta-blockers are not first-line agents for hypertension unless specific indications exist, they can be added to the treatment regimen when needed 1, 2

Dosing Considerations

  • The American College of Cardiology recommends metoprolol tartrate to be typically dosed at 100-200 mg daily in two divided doses, while metoprolol succinate is dosed at 50-200 mg once daily 2, 4
  • The American Heart Association suggests lisinopril to be typically dosed at 20-40 mg once daily for hypertension 4

Special Populations and Considerations

  • The American College of Cardiology suggests that the combination is particularly beneficial in patients with heart failure with reduced ejection fraction 2, 3
  • The European Society of Cardiology recommends caution in patients with symptomatic orthostatic hypotension, moderate-to-severe frailty, and advanced age (≥85 years) 1

Important Precautions

  • The American College of Cardiology advises against abrupt cessation of beta-blockers like metoprolol 2, 4
  • The European Society of Cardiology recommends avoiding the combination of two RAS blockers (such as an ACE inhibitor with an ARB) 1, 2

Clinical Pearls

  • The European Society of Cardiology recommends fixed-dose single-pill combinations to improve adherence 1
  • The American College of Cardiology suggests that medications should be taken at the most convenient time of day for the patient to establish a habitual pattern and improve adherence 1
  • The American College of Cardiology includes both metoprolol and lisinopril in the standard guideline-directed medical therapy for patients with heart failure 3